GRAIL,LLC
About GRAIL,LLC
104 articles about GRAIL,LLC
-
GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation 5/13/2019 多Cancer Test Proprietary Methylation Technology选定项 -
Companies are filling in the gaps and the entire area of so-called“liquid biopsies”is hot these days,with companies like Guardant Health,Karius,Freenome,Apostle and GRail Bio entering the market。 With this backdrop,let’s look at some companies working in the same field as the now-defunct T。。。 -
GRAIL Announces Appointment of Catherine Friedman as Chair of GRAIL Board 12/10/2018 配电盘,配电盘,配电盘,配电盘,配电盘 -
GRAIL Announces Plans to Initiate SUMMIT Study to Support Development of Blood Test for Early Cancer Detection 12/4/2018 SUMMIT Study Partners Include UCL and University College London Hospitals NHS Foundation Trust in the United Kingdom,and Lung Cancer Alliance -
Johnson&Johnson’s JLABS incubator in San Francisco recently convened a meeting of biopharma industry executives.One of the hot topics for one of the panels was the competition for talent。 -
GRAIL to Present New Data fr the Circulating Cell-free Genome Atlas(CCGA)Study at the European Society for Medical Oncology(ESMO)2018 Congress 10/19/2018 GRAIL,Inc.today announced that new data from the Circulating Cell-free Genome Atlas(CCGA)study will be presented by Minetta Liu,MD,Research Chair and Professor,Department of Oncology,Mayo Clinic,in an oral presentation at the European Society for Medical Oncology(ESMO)2018 in Munich,Germany。 -
Investor Entusiasm About Liquid Biopsies Drives Guardant Health IPO to$1.59 Billion Valuation 10/5/2018 Guardant Health went on the Nasdaq yesterday under the symbol GH.Shares climbed almost70percent on the first day of trading,selling12.5million shares at$19per share in the initial public offering(IPO)。 -
GRAIL Announces Appointment of Renée Galáas Chief Financial Officer 10/4/2018 GRAIL,Inc.,healthcare company whose mission is to detect cancer early,when it can be cured,today announced the appointment of Renée Galáas Chief Financial Officer, effective January3,2019。 -
It’s been a hot year for biotech initial public offerings(IPOs)。 Two recent announced offerings,Kodiak Sciences in Palo Alto and Guardant Health in Redwood City mark the fourteenth and fifteenth life sciences IPOs in the San Francisco Bay Area this year。 -
Biotech Movers and Shakers for Aug.13 8/13/2018 GSK's Hal Barron,former Juno Chief Executive Officer and others take on or transition into new roles.Let's take a look at some of those! -
GRAIL Announces Appointment of Hal Barron and Hans Bishop to its Board of Directors 8/9/2018 GRAIL,Inc.announced the appointment of Hal Barron,MD,and Hans Bishop to its Board of Directors。 -
San Francisco-based Mammoth Biosciences,co-founded by one of the originators of CRISPR gene editing,Jennifer Doudna,closed on a$23million Series A financing round。 -
So far in 2018,it’s been a good year for biotech initial public offerings(IPOs)。 According to a Crunchbase News article,in the second quarter of this year alone,there were at least16U.S.venture-backed biotech and healthcare IPOs—compared to only11tech IPOs in the same period。 -
GRAIL Announces Appointment of Key Executives as Company Makes Continued Progress in Development of Early Detection Products 7/9/2018 George Golumbeski Appointed as President -
Hebrew University Researchers to Collaborate With GRAIL 6/12/2018 四角cancer检测 -
With the 2018 American Society of Clinical Oncology(ASCO)Annual Meeting ongoing, there are hundreds of newsworthy stories.Here is a few of our top picks so far。 -
GRAIL Announces Data on Detection of Early-Stage Lung Cancers 6/2/2018 GRAIL,Inc.announced new data from the Circulating Cell-free Genome Atlas(CCGA)study。 -
Six Biotechs Launch IPO Plans in Last Days of May,While Iterum Therapeutics Adjusts IPO Goals 5/29/2018 It’s been a busy month for IPOs.Numerous biotech companies announced their intentions to publicly list their stock on an exchange in the U.S.or abroad in order to gain new funding to advance developmental programs。 -
Grail Raises$300 Million至China Investors为Early Cancer诊断程序 5/23/2018 Grail announced a$300million C financing.Since early2016,Grail has raised over$1.5billion。 -
With anew chief executive officer on board,GRAIL,Inc.has secured awhopping$300million in an oversubscribed Series C financing round led by multiple Chinese investment groups。